Articles about Kineta

Seattle biotech company Kineta lays off majority of staff, including its CEO

Kineta announced Thursday that it is laying off 64% of its workforce, or seven employees — including its CEO Shawn… Read More

Tech Moves: Madrona adds three new venture partners; DexCare hires exec; and more

— Seattle venture capital firm Madrona Venture Group announced it added three new venture partners: Loren Alhadeff, Mark Nelson, and… Read More

Seattle biotech company Kineta completes merger, begins trading on Nasdaq

Seattle biotech company Kineta completed its merger with Yumanity Therapeutics, a move that makes Kineta a public company. The combined… Read More

Tech Moves: Glassdoor hires former Convoy chief economist; Kineta adds exec; and more

— Maggie Brady, previously a human resources group leader at fintech company Fiserv, is now head of people at trucking… Read More

Seattle biotech Kineta will go public in deal with neurosciences company Yumanity Therapeutics

Seattle biotech company Kineta is going public through a merger with Yumanity Therapeutics, a neurosciences company based in Boston. Yumanity… Read More

Vote for your favorite Health Innovation of the Year, a new category at the GeekWire Awards

Proteins, algorithms and apps — oh my! Health innovators across the Pacific Northwest continue to embrace technologies that go well… Read More

Biotech startup Kineta inks cancer deal with Pfizer worth up to $505M

Seattle-based biotech startup Kineta today received a leg-up in its efforts to kill cancerous tumors using the immune system. Kineta announced an… Read More

Kineta signs multi-million dollar collaboration with Genentech to develop non-opioid pain medication

As the U.S. opioid epidemic rages on, the need for effective alternative pain medications is only becoming more acute. Seattle-based… Read More

Biotech startup tries unique weapon in fight against chronic pain and opioid addiction: snail venom

If you didn’t know snails could be venomous, you’re not alone. But it turns out some are, and a recent… Read More

This Seattle biotech startup just secured funding to tackle the Zika virus

Seattle-based biotech startup Kineta announced today that it has received an undisclosed amount of funding to expand research that could… Read More

Kineta wins $7.2M award to develop antiviral drug focused on Lassa fever

Seattle-based biotech startup Kineta today announced that it won a $7.2 million award to develop an antiviral drug therapy for… Read More

Kineta wins $4M award to develop therapies against viral diseases like Ebola, influenza, others

Seattle-based biotech startup Kineta today announced that it won a $4 million federal contract from the National Institute of Allergy and… Read More

Kineta and partners raising funds to ‘break out of the old biotech model’

A consortium that includes Seattle-based biotech company Kineta, UW Medicine, and the University of Washington’s CoMotion group is seeking to raise an… Read More

Seattle biotech firm Kineta raises $1.6 million to boost its battle against disease

Kineta, a Seattle-based biotech startup, has raised an investment round worth almost $1.6 million from existing investors in the company.… Read More

Kineta, UW receive biodefense grant to study ways to wipe out deadly viruses like Ebola

The University of Washington, University of Texas Medical Branch and Kineta — a Seattle biotechnology upstart — have received an… Read More